Physicians Office Resource Volume 11 Issue 01

BUYERS GUIDE 2017 Physicians office Resource ™ The 2017 Physicians Office Resource Buyers Guide FOR ADULTS WITH ESTABLISHED CV DISEASE* AND TYPE 2 DIABETES A groundbreaking innovation in CV care is here REDUCE THE RISK OF CV DEATH WITH JARDIANCE Learn more at INDICATION AND LIMITATIONS OF USE † JARDIANCE is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. JARDIANCE is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS JARDIANCE should not be used in patients with a history of serious hypersensitivity to JARDIANCE or in patients with severe renal impairment, end-stage renal disease, or dialysis. WARNINGS AND PRECAUTIONS Hypotension JARDIANCE causes intravascular volume contraction and symptomatic hypotension may occur. Before initiating JARDIANCE, assess and correct volume status in the elderly, in patients with renal impairment, low systolic blood pressure, or on diuretics. Monitor for hypotension. Ketoacidosis Reports of ketoacidosis, a serious lifethreatening condition requiring urgent hospitalization have been identified in patients with type 1 and type 2 diabetes mellitus receiving sodium glucose co transporter 2 (SGLT2) inhibitors, including JARDIANCE. Fatal cases of ketoacidosis have been reported in patients taking JARDIANCE. Patients who present with signs and symptoms of metabolic acidosis should be assessed for ketoacidosis, even if blood glucose levels are less than 250 mg/dL. If suspected, discontinue JARDIANCE, evaluate and treat promptly. *Patients with coronary artery disease, peripheral artery disease, or a history of myocardial infarction or stroke. CV=cardiovascular. Before initiating JARDIANCE, consider risk factors for ketoacidosis. Patients on JARDIANCE may require monitoring and temporary discontinuation in situations known to predispose to ketoacidosis. 2017 BUYERS GUIDE Please see Important Safety Information and Brief Summary of Prescribing Information on adjacent pages. LIFESAVING CV BENEFIT † 1